Ralph Malacrida
Direttore/Membro del Consiglio presso Novo Nordisk Pharma AG
Profilo
Ralph Malacrida currently works at Novo Nordisk Pharma AG, as Member-Supervisory Board and Novo Nordisk Health Care AG, as Member-Supervisory Board.
Posizioni attive di Ralph Malacrida
Società | Posizione | Inizio |
---|---|---|
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Direttore/Membro del Consiglio | - |
Novo Nordisk Health Care AG
Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |
Novo Nordisk Health Care AG
Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Ralph Malacrida